EP2916859
METHOD OF REDUCING ADVERSE EFFECTS IN A CANCER PATIENT UNDERGOING TREATMENT WITH A MEK INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.11.2013EP published:
28.6.2017EP application number:
13792162.3
EPO information:
European Patent Register
Max expiry date:
31.10.2033
Title:
METHOD OF REDUCING ADVERSE EFFECTS IN A CANCER PATIENT UNDERGOING TREATMENT WITH A MEK INHIBITOR
Timeline
Today
1.11.2013EP application
28.6.2017EP Publication
Owner
Name:
The U.S.A. as represented by the Secretary, Department of Health and Human ServicesAddress:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325, MSC 7660, 20892-7660, Bethesda, MD, US
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293, Darmstadt, DE
Inventor
Name:
MILLER, Sheldon S.Address:
Bethesda, MD, US
Name:
MAMINISHKIS, ArvydasAddress:
Washington, D.C., US
Name:
REMÉ, Charlotte E.Address:
Zürich, CH
Priority
Number:
201261721810 PDate:
2.11.2012Country:
US
Classification
Categories:
A61K 38/21, A61P 27/00